SHLT SHL Telemedicine, Ltd.: Earnings per share for the last twelve months

Public company logo of SHL Telemedicine, Ltd. (SHLT)

Global demand for remote cardiac monitoring is steadily rising, as confirmed by the trailing twelve-month EPS YoY trend. The SHL Telemedicine Ltd. (SHLT) ecosystem integrates AI analysis and ECG devices to create a closed-loop treatment circuit. Management is focusing on US expansion via wearable devices. The current value of shows the earnings per share, helping to assess the real value of the business.

SHL Telemedicine, Ltd. - SHLT Net earnings per share for the last 12 months (period 07/04/2022 - 11/18/2026)

SHLT (shl-telemedicine.com): analytical breakdowns and indicator data

Fundamental company valuation:SHLT, SHL Telemedicine, Ltd.
Core merchandise of SHL Telemedicine Ltd.

To objectively assess the operational efficiency of SHL Telemedicine Ltd. (SHLT), investors must track net income dynamics. This 12-month YoY EPS growth chart measures the percentage change in earnings per share, revealing the sensitivity of profitability to macroeconomic pressure. The positive trend confirms the resilience of the business model. Stable cardiology monitoring subscriptions in Europe create a predictable cash flow, which minimizes capital risks amid high borrowing costs.